Reach Neuro ( SOSV Accelerator)

Funding Details
Awarder
SOSV
Date Award
May 13, 2024
Vertical
Biopharma
Funding URL
View Funding Page

Company Info
Traction
None
Organizations Involved
None
Founders
Marc Powell, Angelica Herrera
Company Description
At Reach Neuro, Inc. we don’t believe that disability due to chronic stroke should mean an end to independence or the ability to participate in the activities you love. We are developing the first-ever treatment for upper-limb paralysis caused by stroke. Our technology uses an implantable neuromodulator to stimulate the spinal cord, working with the nervous system to restore motor function, even 9 years post-stroke.
Market
Therapeutics
Location
United States
Coinvestors
None

Links
Back to Home Back to Biopharma Deals View Funding Announcement